猴痘的临床特征与诊疗分析

doi:10.12114/j.issn.1007-9572.2024.0466

中国全科医学 ›› 2026, Vol. 29 ›› Issue (11): 1430-1433.DOI: 10.12114/j.issn.1007-9572.2024.0466

所属专题：安宁疗护专题研究

• 论著 • 上一篇

猴痘的临床特征与诊疗分析

吴延延, 邓前程, 罗丽敏, 朱伟芳^*()

310003　浙江省杭州市，浙江大学医学院附属第一医院皮肤科

收稿日期:2024-06-10 修回日期:2024-10-10 出版日期:2026-04-15 发布日期:2024-11-06
通讯作者: 朱伟芳
作者贡献：
吴延延负责文献收集、采集及论文起草；邓前程负责框架构建，论文核对；罗丽敏提出研究思路；朱伟芳负责最终版本修订，对论文整体负责。
基金资助:
国家青年科学基金项目(82103708); 浙江省基础公益研究项目(LGF21H90004)

Clinical Characteristics and Diagnosis and Treatment Analysis of Monkeypox

WU Yanyan, DENG Qiancheng, LUO Limin, ZHU Weifang^*()

Department of Dermatology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China

Received:2024-06-10 Revised:2024-10-10 Published:2026-04-15 Online:2024-11-06
Contact: ZHU Weifang

分享到

摘要/Abstract

摘要： 2022-07-23和2024-08-14，世界卫生组织两次宣布猴痘（monkeypox）疫情构成国际关注的突发公共卫生事件（PHEIC）。2022年全球暴发的猴痘疫情中，男同性恋和双性恋男性占了绝大多数，但2024年疫情主要受累人群是妇女和15岁以下儿童及青少年。本文基于两次PHEIC，从猴痘的病原学、流行病学、临床表现、诊断、共病筛查、皮疹的鉴别诊断、治疗、预防等8个维度进行讨论，重点分析两次疫情的相同及不同点，尤其是针对皮疹变化展开叙述，从斑疹→丘疹→水疱→脓疱→结痂变化过程鉴别诊断，着重于皮肤科视角诊疗猴痘，旨在为其临床防治提供新的参考。

关键词: 猴痘, 皮肤病学, 疹, 诊断, 治疗

Abstract:

On July 23, 2022 and August 14, 2024, the World Health Organization declared the daily outbreak of monkeypox as a Public Health Emergency of International Concern (PHEIC) twice. While gay and bisexual men constituted the majority of cases in 2022, women and children under 15 years old were the primary victims of the 2024 outbreak. This paper examines the etiology, epidemiology, clinical manifestations, diagnosis, comorbidity screening, differential diagnosis, treatment and prevent of monkeypox in light of these two PHEICs. It particularly focuses on elucidating similarities and differences between the two outbreaks. Emphasizing changes in skin rash progression from macules to papules to vesicles to pustules to scabs is introduced for differential diagnosis purposes. The discussion also highlights dermatological perspectives on diagnosing and treating monkeypox with an aim to offer new insights for clinical prevention and treatment.

Key words: Monkeypox, Dermatology, Exanthema, Diagnosis, Treatment

中图分类号:

R-332

吴延延,邓前程,罗丽敏,等. 猴痘的临床特征与诊疗分析[J]. 中国全科医学, 2026, 29(11): 1430-1433. DOI: 10.12114/j.issn.1007-9572.2024.0466.
WU Yanyan,DENG Qiancheng,LUO Limin, et al. Clinical Characteristics and Diagnosis and Treatment Analysis of Monkeypox[J]. Chinese General Practice, 2026, 29(11): 1430-1433. DOI: 10.12114/j.issn.1007-9572.2024.0466.

参考文献 20

[1]	LADNYJ I D, ZIEGLER P, KIMA E. A human infection caused by monkeypox virus in Basankusu Territory, Democratic Republic of the Congo[J]. Bull World Health Organ, 1972, 46(5): 593-597.
[2]	MITJA O, OGOINA D, TITANJI B K, et al. Monkeypox [J]. Lancet, 2023, 401(10370): 60-74. DOI: 10.1016/S0140-6736(22)02075-X.
[3]	ZHAO H, WANG W L, ZHAO L, et al. The first imported case of monkeypox in the mainland of China - Chongqing municipality, China, September 16, 2022[J]. China CDC Wkly, 2022, 4(38): 853-854. DOI: 10.46234/ccdcw2022.175.
[4]	GIROMETTI N, BYRNE R, BRACCHI M, et al. Demographic and clinical characteristics of confirmed human monkeypox virus cases in individuals attending a sexual health centre in london, UK: an observational analysis[J]. Lancet Infect Dis, 2022, 22(9): 1321-1328. DOI: 10.1016/S1473-3099(22)00411-X.
[5]	国家卫生健康委员会, 国家中医药管理局. 猴痘诊疗指南(2022年版)[EB/OL].(2022-06-10)[2024-05-26].
[6]	国家卫生健康委办公厅. 猴痘防控技术指南(2022年版)[EB/OL].(2022-06-27)[2024-05-26].
[7]	国家传染病医学中心(复旦大学附属华山医院)，中华预防医学会感染性疾病防控分会. 猴痘公众防护指南(2023)[J]. 中华传染病杂志, 2023, 41(10): 623-630. DOI: 10.3760/cma.j.cn311365-20230616-00186.
[8]	KARAGOZ A, TOMBULOGLU H, ALSAEED M, et al. Monkeypox(mpox)virus: classification, origin, transmission, genome organization, antiviral drugs, and molecular diagnosis[J]. J Infect Public Health, 2023, 16(4): 531-541. DOI: 10.1016/j.jiph.2023.02.003.
[9]	THORNHILL J P, BARKATI S, WALMSLEY S, et al. Monkeypox virus infection in humans across 16 countries -April-June 2022[J]. N Engl J Med, 2022, 387(8): 679-691. DOI: 10.1056/NEJMoa2207323.
[10]	ANGELO K M, SMITH T, CAMPRUBÍ-FERRER D, et al. Epidemiological and clinical characteristics of patients with monkeypox in the GeoSentinel network: a cross-sectional study[J]. Lancet Infect Dis, 2023, 23(2): 196-206. DOI: 10.1016/S1473-3099(22)00651-X.
[11]	TARÍN-VICENTE E J, ALEMANY A, AGUD-DIOS M, et al. Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study[J]. Lancet, 2022, 400(10353): 661-669. DOI: 10.1016/S0140-6736(22)01436-2.
[12]	WARD T, CHRISTIE R, PATON R S, et al. Transmission dynamics of monkeypox in the United Kingdom: contact tracing study[J]. BMJ, 2022, 379: e073153. DOI: 10.1136/bmj-2022-073153.
[13]	MCFARLAND S E, MARCUS U, HEMMERS L, et al. Estimated incubation period distributions of mpox using cases from two international European festivals and outbreaks in a club in Berlin, May to June 2022[J]. Eurosurveillance, 2023, 28(27): 1-8. DOI: 10.2807/1560-7917.es.2023.28.27.2200806.
[14]	SUKHDEO S, MISHRA S, WALMSLEY S. Human monkeypox: a comparison of the characteristics of the new epidemic to the endemic disease[J]. BMC Infect Dis, 2022, 22(1): 928. DOI: 10.1186/s12879-022-07900-7.
[15]	LIM C K, MCKENZIE C, DEERAIN J, et al. Correlation between monkeypox viral load and infectious virus in clinical specimens[J]. J Clin Virol, 2023, 161: 105421. DOI: 10.1016/j.jcv.2023.105421.
[16]	NEVES L O, CORDEIRO A D, REZENDE B D C. Dermoscopic findings in human monkeypox infection[J]. An Bras Dermatol, 2023, 98(1): 131-133. DOI: 10.1016/j.abd.2022.10.002.
[17]	GIOVANNI B, MASSONE C. Dermoscopic features of Monkeypox virus skin infection[J]. Dermatol Reports, 2022, 14(4): 9592. DOI: 10.4081/dr.2022.9592.
[18]	MILLER M J, CASH-GOLDWASSER S, MARX G E, et al. Severe monkeypox in hospitalized patients - United States, August 10-October 10, 2022[J]. Morb Mortal Wkly Rep, 2022, 71(44): 1412-1417. DOI: 10.15585/mmwr.mm7144e1.
[19]	SHERWAT A, BROOKS J T, BIRNKRANT D, et al. Tecovirimat and the treatment of monkeypox-past, present, and future considerations[J]. N Engl J Med, 2022, 387(7): 579-581. DOI: 10.1056/NEJMp2210125.
[20]	RASTOGI A, KUMAR M. Current status of vaccine development for monkeypox virus[J]. Adv Exp Med Biol, 2024, 1451: 289-300. DOI: 10.1007/978-3-031-57165-7_18.

猴痘的临床特征与诊疗分析

Clinical Characteristics and Diagnosis and Treatment Analysis of Monkeypox

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 20

相关文章 15

编辑推荐

Metrics

留言

[1]	褚洪川, 孙松朋, 龙俊红, 霍兴霄, 梁隆雨, 周阳洋, 刘彦, 刘甲鑫. Giordano痔病症状严重程度评分评价痔病严重程度的有效性和指导治疗的价值研究[J]. 中国全科医学, 2026, 29(11): 1405-1410.
[2]	黄颖, 周智远, 潘志雄, 祝群. 代谢功能障碍相关脂肪性肝病与2型糖尿病及心血管并发症相关性研究进展[J]. 中国全科医学, 2026, 29(09): 1212-1216.
[3]	王晨瑜, 王晓艳, 张立秀, 王丽娜. 轻度认知障碍人群社区筛查与诊断管理策略的研究进展[J]. 中国全科医学, 2026, 29(08): 1037-1043.
[4]	赵倩倩, 张梅, 李艳英, 张艳红, 晏文华, 潘慧, 班博. 生长激素缺乏症的临床特征与重组人生长激素疗效分析：一项十年纵向队列研究[J]. 中国全科医学, 2026, 29(06): 733-740.
[5]	张彦景, 周春华, 李晓东, 刘琰, 王婧, 于静. 文拉法辛血药浓度超警戒值风险预测模型的临床价值研究[J]. 中国全科医学, 2026, 29(06): 777-782.
[6]	梁灵君, 张军, 陈建辉, 高永双. 2022—2024年利培酮治疗药物监测结果的回顾性分析[J]. 中国全科医学, 2026, 29(06): 783-789.
[7]	杨海飞, 孙武, 吴成, 任伟, 李茹恬. 进展期食管鳞状细胞癌免疫相关不良反应的预测因素及其与疗效相关性分析[J]. 中国全科医学, 2026, 29(06): 710-717.
[8]	周睿, 金玥, 刘婷婷, 蔡可润, 崔译元, 李思聪, 刘丽星, 冯利, 骨继发恶性肿瘤中西医结合诊疗指南工作组. 骨继发恶性肿瘤中西医结合诊疗指南[J]. 中国全科医学, 2026, 29(04): 423-435.
[9]	王艺衡, 许晓明, 夏云龙, 夏林莺, 韩雪, 郭永珍, 刘泉池, 闫文俊. 射血分数保留的心力衰竭药物治疗进展[J]. 中国全科医学, 2026, 29(03): 403-408.
[10]	中华医学会心身医学分会心身内分泌协作学组, 中华预防医学会糖尿病预防与控制专业委员会. 糖尿病共患抑郁诊疗中国专家共识[J]. 中国全科医学, 2026, 29(03): 273-292.
[11]	陈丽, 熊卫红, 路孝琴. 经皮冠状动脉介入术后患者用药依从性及影响因素研究[J]. 中国全科医学, 2025, 28(36): 4586-4591.
[12]	邵家琛, 李顺平, 杨汀, 张春瑜, 路立勇, 袁佳麒. 利用离散选择试验测量慢性阻塞性肺疾病患者治疗与装置偏好的综述[J]. 中国全科医学, 2025, 28(36): 4648-4654.
[13]	吴慧, 王绿娅, 李嘉璐, 张俊. 《纯合子家族性高胆固醇血症早期筛查与管理中国专家共识（2024年）》要点解读[J]. 中国全科医学, 2025, 28(36): 4535-4540.
[14]	宋欣芫, 常文秀, 张文玉, 杨婷婷, 王恺. 基于慢性肾脏病数据集的卷积神经网络对慢性肾脏病进展的预测价值研究[J]. 中国全科医学, 2025, 28(35): 4457-4463.
[15]	霍兴霄, 孙松朋, 龙俊红, 梁隆雨, 褚洪川, 周阳洋, 刘彦, 刘甲鑫. 痔的注射治疗在中国的应用现状调查研究[J]. 中国全科医学, 2025, 28(35): 4435-4441.